<?xml version="1.0" encoding="UTF-8"?>
<ref id="B62-vaccines-08-00531">
 <label>62.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hurtado</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bustos</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Granja</surname>
    <given-names>A.G.</given-names>
   </name>
   <name>
    <surname>De Le칩n</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Sabina</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>L칩pez-Vi침as</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>G칩mez-Puertas</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Revilla</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Carrascosa</surname>
    <given-names>A.L.</given-names>
   </name>
  </person-group>
  <article-title>The African swine fever virus lectin EP153R modulates the surface membrane expression of MHC class I antigens</article-title>
  <source>Arch. Virol.</source>
  <year>2010</year>
  <volume>156</volume>
  <fpage>219</fpage>
  <lpage>234</lpage>
  <pub-id pub-id-type="doi">10.1007/s00705-010-0846-2</pub-id>
  <pub-id pub-id-type="pmid">21069396</pub-id>
 </element-citation>
</ref>
